Has Harry Wadsworth received payments from drug or device companies?

Yes. Drug and device makers reported $6,435 in general payments to Harry Wadsworth across 404 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Harry Wadsworth did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Harry Wadsworth come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Harry Wadsworth

Endocrinology, Diabetes & Metabolism · Saint Louis, MONPI 1144213265

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 404 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,941 and has fallen 97.5% since, to $49 in 2024.

$6,435in general payments, 2019–2025

Across 404 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$858
Lilly USA, LLC$619
Amgen$606
Novo Nordisk$573
AbbVie$548
Johnson & Johnson$447
plus $3K from 40 others

What the payments were for

Food & beverage$6,30298%
Education$200%
Gifts$1122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	29	$858
Lilly USA, LLC	48	$619
Amgen(2 entities)	43	$606
Novo Nordisk	41	$573
AbbVie	37	$548
Johnson & Johnson(3 entities)	36	$447
Boehringer Ingelheim	19	$294
Amarin Pharma, Inc.	22	$255
Abbott	9	$240
Biohaven Pharmaceuticals, Inc.	9	$194
Merck	13	$175
Pfizer	11	$152
Novartis	8	$130
Paratek Pharmaceuticals, Inc.	8	$119
GSK	7	$113
Tosoh Bioscience, Inc.	1	$112
Bayer	6	$110
Dexcom, Inc.	5	$85
Insulet Corporation	5	$67
Kowa Pharmaceuticals America, Inc.	5	$65
Recordati_rare_diseases_inc.	3	$64
Eisai Inc.	3	$43
UCB, Inc.	2	$41
Takeda Pharmaceuticals U.S.A., Inc.	3	$39
Xeris Pharmaceuticals, Inc.	2	$35
Sanofi-aventis U.S. LLC	3	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$33
Genentech USA, Inc.	2	$29
Sobi, Inc	1	$29
Exact Sciences	2	$28
Regeneron Healthcare Solutions, Inc.	2	$27
Biohaven Pharmaceutical Holding Company Ltd.	2	$26
Sanofi Pasteur Inc.	2	$23
GE HealthCare	1	$22
E.r. Squibb & Sons, L.L.C.	1	$21
Ultragenyx Pharmaceutical Inc.	1	$21
ANI Pharmaceuticals, Inc.	1	$19
Nestle Healthcare Nutrition Inc.	1	$18
Optos, Inc.	1	$17
Amneal Pharmaceuticals LLC	1	$16
Corcept Therapeutics	1	$16
Medtronic	1	$15
Advanced Respiratory, Inc	1	$15
Scilex Pharmaceuticals Inc.	1	$14
Arbor Pharmaceuticals, Inc.	1	$13
Daiichi Sankyo Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,435 in reported general payments places this provider in the 75th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.

See all endocrinology, diabetes & metabolism providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tresiba Flextouch U-100Insulin Degludec	14	$8,578
Bupropion XlBupropion Hcl	13	$245
Pantoprazole Sodium	13	$193
Atorvastatin Calcium	12	$148
Losartan Potassium	15	$132
Rosuvastatin Calcium	17	$115
Amlodipine Besylate	20	$84
Metoprolol Tartrate	14	$72

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Saint Louis

Janet McGillSaint Louis$212K
Farid RomanSaint Louis$62K
Kathryn DiemerSaint Louis$57K
Julie SilversteinSaint Louis$49K
Michael WhyteSaint Louis$40K
Alexis McKeeSaint Louis$37K
Sandeep DhindsaSaint Louis$36K
Thomas NickolasSaint Louis$35K
K ThampySaint Louis$35K
Garry TobinSaint Louis$30K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →